BamSEC and AlphaSense Join Forces
Learn More

GT Biopharma Inc.

NASDAQ: GTBP    
Share price (3/12/25): $2.49    
Market cap (3/12/25): $5.563 million

Indentures Filter

EX-4.10
from S-3 18 pages Placement Agent Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.2
from 8-K 18 pages Series B Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.1
from 8-K 19 pages Series a Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.37
from S-1/A 17 pages Placement Agent Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.36
from S-1/A 18 pages Pre-Funded Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.35
from S-1/A 17 pages Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.3
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.3
from 8-K 17 pages Placement Agent Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.2
from 8-K 16 pages Pre-Funded Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.2
from 10-K 5 pages Certificate of Designation of Preferences, Rights and Limitations of Series K Preferred Stock of GT Biopharma, Inc
12/34/56
EX-4.3
from S-1/A 14 pages [Form of Pre-Funded Warrant] GT Biopharma, Inc. Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.2
from S-1/A 16 pages [Form of Warrant] GT Biopharma, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 16 pages Convertible Note Due: , 2021
12/34/56
EX-4.1
from 8-K 20 pages Convertible Note Due: , 2021
12/34/56
EX-4.1
from 8-K 21 pages Convertible Note Due
12/34/56
EX-4.1
from 8-K 20 pages Convertible Note Due
12/34/56
EX-4.1
from 8-K 21 pages Convertible Note Due November ___, 2019
12/34/56
EX-4.1
from 8-K 21 pages Secured Convertible Note Due August 2, 2019
12/34/56